Table 4.
DENV-1 | |||||
---|---|---|---|---|---|
Year | Sex, age | Immunity | Clinical presentation | Immediate cause of death | Initial cause of death |
2005 | M, 63 | Secondary | DHF | Fulminating hepatitis | Dengue |
2010 | M, 66 | ND | Acute renal failure, diabetes | MOF | Associated pathology |
2010 | M, 15* | ND | DHF/DSS | Ventilator associated pneumonia | Associated pathology |
2010 | F, 6* | Secondary | DHF/DSS, HbSC Acute thoracic syndrome | MOF | Associated pathology |
2010 | F, 62 | Secondary | DHF/DSS, HbSC | MOF | Associated pathology |
2010 | M, 90 | ND | Heart failure | Cardiogenic shock | Associated pathology |
2010 | F, 42 | ND | DHF/DSS, HbSC | Sudden death | Dengue |
2010 | M, 80 | Secondary | Acute renal failure, diabetes | Acute renal failure | Associated pathology |
2010 | F, 37 | Secondary | DHF/DSS | Sudden death | Dengue |
DENV-2 | |||||
2005 | F, 62 | Secondary | DHF | Head trauma, cerebral hemorrhage | Associated pathology |
2005 | M, 53 | Secondary | DHF | Fulminating hepatitis | Dengue |
2007 | M, 59 | ND | DHF/DSS | Status epilepticus, ventilator associated pneumonia | Associated pathology |
2007 | M, 65 | Primary | DHF/DSS | Encephalitis | Dengue† |
2007 | F, 41 | Secondary | DHF/DSS | Alithiasic gangrenous cholecystitis, septic shock | Dengue |
DENV-4 | |||||
2010 | F, 49 | Secondary | DHF/DSS | MOF | Dengue |
2010 | M, 89 | ND | Heart failure | Pneumonia, cardiogenic shock | Associated pathology |
2010 | M, 1* | ND | DHF/DSS | MOF | Dengue |
2010 | F, 35 | Secondary | DHF/DSS | Sudden death, multifocal myocardial infarction and hepatic necrosis | Dengue† |
2010 | F, 10* | Secondary | DHF/DSS, HbSC | Shock | Dengue† |
2010 | F, 49 | Primary | DSS | Shock | Dengue |
2010 | F, 43 | Secondary | DHF/DSS | Diabetes, lactic acidosis | Associated pathology |
DHF/DSS = dengue hemorrhagic fever/dengue shock syndrome according to WHO definition6; ND = not determined; MOF = multiple organ failure; HbSC = sickle cell disease (SC type).
Not included in the study cohort.
Autopsy case.